Black Rock Inc. Akouos, Inc. Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.6 - $5.16 $14,864 - $29,499	-5,717 Reduced 0.73%	776,992 $5.25 Million
Q2 2022 Aug 12, 2022	SELL	$2.46 - $5.2 $2.94 Million - $6.21 Million	-1,194,485 Reduced 60.41%	782,709 $3.67 Million
Q1 2022 May 12, 2022	SELL	$4.16 - $9.08 $36,408 - $79,468	-8,752 Reduced 0.44%	1,977,194 $9.39 Million
Q4 2021 Feb 10, 2022	BUY	$7.65 - $11.38 $820,814 - $1.22 Million	107,296 Added 5.71%	1,985,946 $16.9 Million
Q3 2021 Nov 09, 2021	BUY	$9.93 - $13.59 $317,918 - $435,097	32,016 Added 1.73%	1,878,650 $21.8 Million
Q2 2021 Aug 11, 2021	BUY	$11.87 - $15.96 $21.9 Million - $29.5 Million	1,846,634 New	1,846,634 $23.2 Million

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.